Dalbergioidin Ameliorates Doxorubicin-Induced Renal Fibrosis by Suppressing the TGF-β Signal Pathway
The expression of Smad7, an inhibitor of the TGF-β signaling pathway, in kidney tissue 5 weeks after DXR injection in different groups of mice as indicated. (a) DAL increases the gene expression of Smad7; (b) DAL increases the protein expression of Smad7. The control and DAL treatment groups are compared with the DXR group. Values are statistically significant at ; the DXR group is compared with the control group. Values are statistically significant at .